ArticlePloS one2019

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

José Manuel Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.